Opening book details…
Can I read Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial on EtoBox?
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial by Fania Z. Muñoz-Garza; Mónica Ríos; Esther Roé-Crespo; José Bernabeu-Wittel; María Teresa Montserrat-García; Luís Puig; Ignasi Gich; Eulalia Baselga is a Medicine article available to read on EtoBox.
What is Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial about?
## Importance: Treatment of infantile hemangioma (ih) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. to our knowledge, no studies have determined whether beginning early treatment with timolol for ih is better than in other proliferative stages. ## Objective: To evaluate the efficacy and safety of timolol maleate solution, 0.5%, for the early treatment of ih in infants younger than 60 days. ## Design, setting, and participants: This multicenter, randomized, double-blind, placebo-controlled, phase 2a pilot clinical trial included patients aged 10 to 60 days with focal or segmental hemangiomas (superficial, deep, mixed, or minimal/arrested growth). patients were randomly assigned to treatment with topical timolol maleate solution, 0.5%, or placebo twice daily for 24 weeks. changes in lesion size (volume, thickness) and color were evaluated from photographs taken at 2, 4, 8, 12, 24, and 36 weeks. vital signs and adverse effects were recorded at each visit. the study was carried out from november 2015 to january 2017, and data analyses were completed in september 2019. ## Main o
Who reads Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Fania Z. Muñoz-Garza; Mónica Ríos; Esther Roé-Crespo; José Bernabeu-Wittel; María Teresa Montserrat-García; Luís Puig; Ignasi Gich; Eulalia Baselga
- Publisher
- American Medical Association (AMA)
- Published
- 2021
- Language
- EN
- Field
- Medicine (Health Sciences)